TNFRSF18 and neoplasm: Checkpoint blockade following TNFR agonists enhances tumor clearance compared to simultaneous administration of both antibodies [3], therefore, we administered GITR agonist Ab first followed by PD-1 Ab blockade in Line-1 tumor-bearing BALB/c mice (Fig. 1a).